Scholars Central

CommentaryPublished 30 Jan 2020

NSAID-induced corneal melt: Clinical importance, pathogenesis and risk mitigation.

Authors: Robert Honkanen, Wei Huang, Basil Rigas

Journal of Clinical Ophthalmology

Volume 4 · Issue 1 · Pages 207–208

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

In the age of evidence-based medicine, non-steroidal antiinflammatory drug (NSAID)-induced corneal melt (NICM) remains a standout in that its prevention, etiology and optimal management are still not guided by well-defined scientific data. NICM, the loss of corneal epithelium accompanied by stromal thinning that can result in ocular perforation and profound vision loss, remains a rare but well accepted entity. In our recent review, we examined the available literature on the clinical features and pathogenesis of NICM, and proposed measures to mitigate its impact on ocular health.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Journal of Clinical Ophthalmology.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Clinical Ophthalmology
  • SubjectOphthalmology & Optometry
  • BylineArticles whose byline prints “Robert Honkanen”
  • BylineArticles whose byline prints “Wei Huang”
  • BylineArticles whose byline prints “Basil Rigas”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels